消化

订阅

MedSci主页 / 所有栏目 / 消化

39种尿液结晶形态汇总

2021-12-17 Sysrnex学术二区 Sysrnex学术二区

尿酸盐尿液检查结晶
关注

39种尿液结晶形态汇总

 

 

来源｜Sysrnex学术二区

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191324, encodeId=1048119132407, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57de6415950, createdName=ms5000000254917531, createdTime=Wed Feb 09 08:14:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181805, encodeId=3f541181805c2, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4acb6418986, createdName=明日何其多, createdTime=Fri Jan 07 12:13:05 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081776, encodeId=a4b91081e76b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab825709185, createdName=ms3000001085877924, createdTime=Sun Dec 19 12:54:17 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449414, encodeId=9954144941449, content=<a href='/topic/show?id=b3e24e442bc' target=_blank style='color:#2F92EE;'>#尿液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47442, encryptionId=b3e24e442bc, topicName=尿液)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66095470791, createdName=zhaohui6733, createdTime=Sun Dec 19 02:00:19 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081382, encodeId=7f4e1081382da, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:28:42 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2022-02-09 ms5000000254917531

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191324, encodeId=1048119132407, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57de6415950, createdName=ms5000000254917531, createdTime=Wed Feb 09 08:14:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181805, encodeId=3f541181805c2, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4acb6418986, createdName=明日何其多, createdTime=Fri Jan 07 12:13:05 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081776, encodeId=a4b91081e76b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab825709185, createdName=ms3000001085877924, createdTime=Sun Dec 19 12:54:17 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449414, encodeId=9954144941449, content=<a href='/topic/show?id=b3e24e442bc' target=_blank style='color:#2F92EE;'>#尿液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47442, encryptionId=b3e24e442bc, topicName=尿液)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66095470791, createdName=zhaohui6733, createdTime=Sun Dec 19 02:00:19 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081382, encodeId=7f4e1081382da, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:28:42 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2022-01-07 明日何其多

    很棒

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191324, encodeId=1048119132407, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57de6415950, createdName=ms5000000254917531, createdTime=Wed Feb 09 08:14:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181805, encodeId=3f541181805c2, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4acb6418986, createdName=明日何其多, createdTime=Fri Jan 07 12:13:05 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081776, encodeId=a4b91081e76b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab825709185, createdName=ms3000001085877924, createdTime=Sun Dec 19 12:54:17 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449414, encodeId=9954144941449, content=<a href='/topic/show?id=b3e24e442bc' target=_blank style='color:#2F92EE;'>#尿液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47442, encryptionId=b3e24e442bc, topicName=尿液)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66095470791, createdName=zhaohui6733, createdTime=Sun Dec 19 02:00:19 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081382, encodeId=7f4e1081382da, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:28:42 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2021-12-19 ms3000001085877924

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191324, encodeId=1048119132407, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57de6415950, createdName=ms5000000254917531, createdTime=Wed Feb 09 08:14:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181805, encodeId=3f541181805c2, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4acb6418986, createdName=明日何其多, createdTime=Fri Jan 07 12:13:05 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081776, encodeId=a4b91081e76b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab825709185, createdName=ms3000001085877924, createdTime=Sun Dec 19 12:54:17 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449414, encodeId=9954144941449, content=<a href='/topic/show?id=b3e24e442bc' target=_blank style='color:#2F92EE;'>#尿液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47442, encryptionId=b3e24e442bc, topicName=尿液)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66095470791, createdName=zhaohui6733, createdTime=Sun Dec 19 02:00:19 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081382, encodeId=7f4e1081382da, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:28:42 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2021-12-19 zhaohui6733

    #尿液#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1191324, encodeId=1048119132407, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57de6415950, createdName=ms5000000254917531, createdTime=Wed Feb 09 08:14:48 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181805, encodeId=3f541181805c2, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4acb6418986, createdName=明日何其多, createdTime=Fri Jan 07 12:13:05 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081776, encodeId=a4b91081e76b2, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab825709185, createdName=ms3000001085877924, createdTime=Sun Dec 19 12:54:17 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449414, encodeId=9954144941449, content=<a href='/topic/show?id=b3e24e442bc' target=_blank style='color:#2F92EE;'>#尿液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47442, encryptionId=b3e24e442bc, topicName=尿液)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66095470791, createdName=zhaohui6733, createdTime=Sun Dec 19 02:00:19 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081382, encodeId=7f4e1081382da, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:28:42 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2021-12-17 ms9000001816745907

    学习了

    0

相关资讯

痛风患者通过联合用药降低血清尿酸

随着我们对炎症小体认识的加深、影像技术的提高，以及改善尿酸盐代谢药物疗法的广为接受，痛风已然成为一个热点话题。 到目前为止，综合性降尿酸治疗（ULT）的药物往往包括使用固定剂量的别嘌呤醇（300mg/天），这种方法只能降低血清尿酸（SUA）浓度，而降低的水平幅度则是随机的。为了达到预定的治疗目标，有时会将别嘌呤醇的剂量逐渐增加到900mg/天。 而来自荷兰内梅亨大学医学中心风湿

Arthritis Rheumatol：别嘌呤醇剂量增加对痛风骨侵蚀和尿酸盐体积的影响

这项研究目的是探讨痛风患者中，为了达到血清尿酸盐目标的别嘌呤醇剂量增加是否会影响通过DECT测量的骨侵蚀或尿酸单钠（MSU）晶体沉积。研究人员对一个为期两年的随机临床试验进行了成像研究，该试验在使用别嘌呤醇且SU≥0.36mmol/L的痛风患者中，比较了别嘌呤醇剂量直接增至血清尿酸盐（SU）目标vs.常规剂量1年，随后剂量增至目标（对照）。在基线、1年和2年随诊时获取足部DECT扫描和X光片（XR

Neurology：尿酸盐水平或预示男性患帕金森病风险

帕金森病是一种运动系统障碍的疾病,主要由于分泌多巴胺的脑细胞减少，通常发生于60岁以上的老人。主要症状有震颤或颤抖、四肢和身体僵硬、运动迟缓、平衡和协调能力受损。症状开始较轻微，随着时间的推移，病情逐渐恶化，进而无法自理。 目前还没有治愈该病的药物,但医务人员采用补充多巴胺的治疗方案，以缓解老人的病情。尿酸是一种强大的抗氧化剂,可消除血液中约60%的自由基。尿酸是嘌呤代谢的终产物。既往研究表明,它

NEJM：乳白色的尿酸盐大疱-案例报道

患者男性，71岁，既往患有痛风病史，曾做过移植术（应用过环保霉素药物），近日他的右手指间关节（以往出现过痛风结节）第二关节处可见白色的水泡样病变（如图A）。